PolyPeptide Group
在场
PolyPeptide Group 是一家在股票代码 PPGN (DE) 下上市的公司。
高管
查看带有其 16 名主要高管的组织结构图
PolyPeptide Group 搜索最多的简介
高管在PolyPeptide Group变化
- Stéphane Varray 曾任 Peptide platform director, 将于 20251月1 现任 Chief Commercial Officer (新闻发布的2024八月9号).
创建提醒
跟踪 PolyPeptide Group 的高管变动
药店
PolyPeptide Group 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
PolyPeptide Group 的最新新闻稿
- Large-scale SPPS capacity in Braine-l’Alleud starts production - Polypeptide
- PolyPeptide supports landmark publication on sustainable peptide synthesis - Polypeptide
- Patric Rombo, Polypeptide
- Vinnova grant awarded to joint project between PolyPeptide and Red Glead Discovery for developing a more sustainable manufacturing method for a GLP-1 agonist. - Polypeptide
- News - Page 14 of 14 - Polypeptide
- Advancing Sustainable Peptide Synthesis by Solvent Quality Control: Understanding and Mitigating Hydroperoxide in 1-Butyl-2-pyrrolidinone (NBP) - Polypeptide
- Research article: Sustainable PFAS-free alternatives for TFA in SPPS - Polypeptide
- Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028 - Polypeptide
- PolyPeptide appoints Chief Commercial Officer - Polypeptide
- Trending topics at PolyPeptide - Polypeptide
- View more press releases Close
通过电子邮件
